La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Astrana Health Gestion
Gestion contrôle des critères 2/4
Le PDG Astrana Health's est Brandon Sim, nommé en Jan2024, a un mandat de moins d'un an. La rémunération annuelle totale est $ 14.31M, composée du salaire de 5% et des bonus 95%, y compris les actions et options de la société. détient directement 3.09% des actions de la société, d'une valeur de $ 73.13M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.1 ans et 5.6 ans.
Informations clés
Brandon Sim
Directeur général
US$14.3m
Rémunération totale
| Pourcentage du salaire du PDG | 5.0% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 3.1% |
| Durée moyenne d'occupation des postes de direction | 1.2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.7yrs |
Mises à jour récentes de la gestion
Recent updates
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$68m |
| Mar 31 2024 | n/a | n/a | US$62m |
| Dec 31 2023 | US$14m | US$712k | US$61m |
| Sep 30 2023 | n/a | n/a | US$45m |
| Jun 30 2023 | n/a | n/a | US$46m |
| Mar 31 2023 | n/a | n/a | US$45m |
| Dec 31 2022 | US$15m | US$670k | US$45m |
| Sep 30 2022 | n/a | n/a | US$58m |
| Jun 30 2022 | n/a | n/a | US$69m |
| Mar 31 2022 | n/a | n/a | US$70m |
| Dec 31 2021 | US$9m | US$364k | US$69m |
| Sep 30 2021 | n/a | n/a | US$70m |
| Jun 30 2021 | n/a | n/a | US$53m |
| Mar 31 2021 | n/a | n/a | US$47m |
| Dec 31 2020 | US$1m | US$124k | US$38m |
| Sep 30 2020 | n/a | n/a | US$35m |
| Jun 30 2020 | n/a | n/a | US$22m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$73k | US$24k | US$14m |
Rémunération vs marché: La rémunération totale de Brandon ($USD 14.31M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 5.62M ).
Rémunération et revenus: La rémunération de Brandon a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Brandon Sim (30 yo)
less than a year
Titularisation
US$14,311,250
Compensation
Mr. Brandon K. Sim, MS, is President and Chief Executive Officer at Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.) since January 19, 2024 and had been its Co-Chief Executive Officer...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.8yrs | US$5.22m | 2.4% $ 66.5m | |
| President & CEO | less than a year | US$14.31m | 3.09% $ 85.7m | |
| Co-Founder & Vice Chairman | less than a year | US$5.22m | 3.07% $ 85.2m | |
| CFO, COO & Corporate Secretary | 2.3yrs | US$5.70m | 0.31% $ 8.5m | |
| Senior Vice President of Health Affairs | less than a year | US$562.77k | 2.41% $ 67.0m | |
| Chief Accounting Officer | 2.2yrs | pas de données | 0.037% $ 1.0m | |
| Vice President of People & Operations | no data | pas de données | pas de données | |
| Chief Quality Officer | 3.5yrs | pas de données | pas de données | |
| President of Provider Solutions | 2.7yrs | pas de données | pas de données | |
| Chief Medical Officer for Texas | 1.2yrs | pas de données | pas de données | |
| Chief Medical Officer | less than a year | pas de données | 0.30% $ 8.5m | |
| Managing Director of the Capital Markets Group | less than a year | pas de données | pas de données |
1.2yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Gestion expérimentée: L'équipe de direction de ASTH n'est pas considérée comme expérimentée (ancienneté moyenne 1.1 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.8yrs | US$5.22m | 2.4% $ 66.5m | |
| Co-Founder & Vice Chairman | less than a year | US$5.22m | 3.07% $ 85.2m | |
| Independent Director | 2.8yrs | US$211.95k | 0.015% $ 407.9k | |
| Lead Independent Director | 6.8yrs | US$374.01k | 0.036% $ 1.0m | |
| Independent Director | 11.3yrs | US$329.87k | 0.019% $ 526.6k | |
| Independent Director | 5.7yrs | US$273.71k | 0.032% $ 895.9k | |
| Director | 5yrs | US$274.13k | 0.017% $ 470.0k | |
| Director | 5.7yrs | US$211.95k | 0.16% $ 4.4m | |
| Independent Director | 2.8yrs | pas de données | pas de données |
5.7yrs
Durée moyenne de l'emploi
70yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ASTH sont considérés comme expérimentés (ancienneté moyenne 5.6 ans).